ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 103 filers reported holding ENDOCYTE INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $841,000 | +28.8% | 47,349 | 0.0% | 0.39% | +20.6% |
| Q2 2018 | $653,000 | +51.9% | 47,349 | 0.0% | 0.32% | +52.1% |
| Q1 2018 | $430,000 | +111.8% | 47,349 | 0.0% | 0.21% | +119.8% |
| Q4 2017 | $203,000 | +203.0% | 47,349 | 0.0% | 0.10% | +174.3% |
| Q3 2017 | $67,000 | -5.6% | 47,349 | 0.0% | 0.04% | -10.3% |
| Q2 2017 | $71,000 | +7.6% | 47,349 | +68.3% | 0.04% | +8.3% |
| Q1 2017 | $66,000 | +4.8% | 28,141 | 0.0% | 0.04% | -7.7% |
| Q4 2016 | $63,000 | -55.6% | 28,141 | -40.6% | 0.04% | -55.2% |
| Q3 2016 | $142,000 | -6.6% | 47,349 | 0.0% | 0.09% | -7.4% |
| Q2 2016 | $152,000 | +50.5% | 47,349 | +45.5% | 0.09% | +16.0% |
| Q1 2016 | $101,000 | -22.3% | 32,541 | 0.0% | 0.08% | -24.3% |
| Q4 2015 | $130,000 | – | 32,541 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |